Fig. 3
From: AGGF1-primed endothelial progenitor cells alleviate ischaemia-reperfusion injury in diabetic hearts
AGGF1-primed EPCs therapy markedly alleviates I/R injuries in mice hearts. (A) Overview of the T2DM model procedure. (B) IPGTT assay for C57BL/6 J mice after HFD + STZ, n = 6. (C) IPITT assay for C57BL/6 J mice after HFD + STZ, n = 6. (D–F) LDH, cTnT, and CK-MB activities in the serum (36 h post I/R). n = 6. Data are mean ± SD. *P < 0.05, ***P < 0.001, ****P < 0.0001.
